IQVIA Holdings Inc. Receives 'Moderate Buy' Consensus Rating from Analysts

Shares of IQVIA Holdings Inc. (NYSE:IQV) currently hold an average rating of 'Moderate Buy' based on reports from twenty-one ratings firms monitoring the stock, as noted by MarketBeat.com. Among those analysts, three have issued a hold rating while seventeen recommend buying, and one analyst suggests a strong buy for the company. The consensus price target for IQVIA stock over the next twelve months is $255.71.

Recent Analyst Reports

IQVIA has recently attracted attention from several analysts. For instance, Truist Financial reduced its price target for the stock from $265.00 to $261.00 but maintained a 'buy' rating in its report dated December 12th. Similarly, William Blair reaffirmed an 'outperform' rating on December 11th. Evercore ISI also lowered its target price from $270.00 to $265.00, indicating an 'outperform' rating in a research note on October 8th. Meanwhile, Deutsche Bank Aktiengesellschaft adjusted its target from $270.00 to $265.00, supporting a 'buy' rating in a note released on November 1st. Lastly, BTIG Research also revised its price target downward from $290.00 to $260.00 while maintaining a 'buy' recommendation.

IQVIA Stock Overview

As of Friday, IQVIA shares opened at $204.54. The stock has shown a 50-day moving average of $199.71 and a 200-day moving average of $221.06. Its financial ratios include a debt-to-equity ratio of 1.76, a current ratio of 0.81, and a quick ratio of 0.81. IQVIA's market capitalization stands at approximately $37.12 billion, with a price-to-earnings (PE) ratio of 26.84 and a price-to-earnings-growth (PEG) ratio of 2.14. Over the past year, the stock has traded between a low of $187.62 and a high of $261.73.

Institutional Investor Activity

Recent activity among institutional investors is notable as many have bought or sold shares of IQVIA. For example, Capital Performance Advisors LLP initiated a new position during the third quarter, investing around $27,000. Park Place Capital Corp also acquired a new stake valued at about $28,000 during the same period. Additionally, Avior Wealth Management LLC increased its holdings in IQVIA by 117.6% and currently owns 161 shares worth $38,000 after purchasing 87 additional shares in the last quarter. Synergy Asset Management LLC established a new position valued at $33,000 in the fourth quarter, while Assetmark Inc. raised its stake by 612.5% during the third quarter, now owning 228 shares worth $54,000 after acquiring 196 shares in recent months. Overall, 89.62% of IQVIA's stock is held by institutional investors and hedge funds.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services tailored for the life sciences sector across the Americas, Europe, Africa, and the Asia-Pacific regions. The company operates primarily in three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Final Thoughts

This comprehensive understanding of IQVIA Holdings Inc. reveals its steady performance amid analyst recommendations and institutional interest, making it a notable player in the healthcare analytics market.

IQVIA, Stock, Analysts